T Cell Sciences Inc. named Jacqueline Arthur vice president andchief financial officer. She was vice president of finance forMIA Com.
Jeffrey F. McKelvy was named vice president of Ciba-Geigy'spharmaceutical division. He was venture head of neurosciencesfor Abbott Laboratories.
Cortecs International Ltd. appointed Ronald Wing non-executive director. He is chairman of the NHS Central BloodLaboratories Authority, vice chairman of East Yorkshire HealthAuthority and a member of council at the School of Pharmacy,London University.
CytoMed has appointed Steve E. Reese vice president ofbusiness development. He was president of the pharmaceuticaldivision and chief operating officer at Competence AssuranceSystems, Inc.
PerSeptive Biosystems Inc. named John Curling vice president,international business development. He previously held severalpositions at Pharmacia.
John W. Fara, president and chief executive officer at AnergenInc., has joined Iomed's board of directors.
MedClone has named John A. Hardin, Irvin S.Y. Chen andAldons J. Lusis to its scientific advisory board. Hardin is thechairman of the department of medicine at the Medical Collegeof Georgia. Chen is the director of the UCLA AIDS Institute, andLusis is a professor in the department of medicine andmicrobiology at UCLA.
Hybridon Inc. named John Goodchild vice president ofribozyme research. He worked at the Worcester Foundation forExperimental Biology.
ImmunoGen Inc. appointed Donal E. O'Neill to its board ofdirectors. He is a board member of Noval pharmaceutical Corp.,and Alliance Pharmaceutical.
Idexx Laboratories Inc. elected James L. Moody Jr. to its boardof directors. He is chairman of the board at Hannaford Bros. Co.
RML Medical Laboratories Inc. appointed Barry J. Reiter to itsboard of directors. He is a partner in the law firm of Tory, Tory,Deslauriers & Binnington.
Vestar Inc. named James A. Eskridge to its board of directors.He is executive vice president of finance and administration forMattel Toys Inc.
Allelix Biopharmaceuticals Inc. named Irving Johnson to itsboard of directors. He is a consultant and a member of thecompany's scientific development advisory board.
Medtronic Inc. named Michael Selzer general manager of thecompany's Promeon division. He maintains his position as vicepresident and general manager of the company's Micro-Reldivision.
(c) 1997 American Health Consultants. All rights reserved.